Hand-Foot-Syndrome (Hfs) Is A Strong Predictor For Os And Pfs In Her2-Negative Metastatic Breast Cancer (Mbc) Treated With First-Line Capecitabine (Cap) Plus Bevacizumab (Bev): Results Of A Subanalysis Of The Randomized Phase Iii Cecog Turandot Trial

CANCER RESEARCH(2015)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要